Metronidazole vs. Macrobid

See how Metronidazole and Macrobid compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Metronidazole treats anaerobic bacterial and protozoal infections like bacterial vaginosis and trichomoniasis, while Macrobid is used specifically for uncomplicated urinary tract infections.

  • Both drugs can cause nausea and headache, but metronidazole carries a boxed warning for carcinogenicity and a severe reaction with alcohol that Macrobid does not share.

  • Macrobid concentrates in urine and works poorly outside the urinary tract, while metronidazole reaches therapeutic levels throughout the body.

Metronidazole vs. Macrobid Drug Summary

Metronidazole

Metronidazole is a nitroimidazole antibiotic used to treat anaerobic bacterial infections, trichomoniasis, bacterial vaginosis, and amebiasis. It is taken orally, usually two to three times a day for 7 to 10 days depending on the infection, and also comes as an IV, topical, or vaginal formulation.

Macrobid

Macrobid (nitrofurantoin) is a urinary anti-infective used only for uncomplicated bladder infections caused by susceptible E. coli or S. saprophyticus. It is taken orally as one 100 mg capsule every 12 hours for 7 days and works almost entirely within the urinary tract.

Metronidazole vs. Macrobid Side Effects

Metronidazole

Most common
Nausea (up to 12%)
Headache (up to 6%)
Metallic taste (up to 10%)
Diarrhea (up to 5%)

Macrobid

Most common
Nausea (up to 8%)
Headache (up to 6%)
Flatulence (up to 1.5%)
Vomiting (up to 1%)

Metronidazole vs. Macrobid Dosage

Metronidazole

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg three times daily Days 1-7
Maximum dose 500-750 mg three times daily If needed
Dose changes 2 increases As tolerated

Macrobid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg every 12 hours Days 1-7
Maximum dose 100 mg every 12 hours Same as starting
Dose changes None Fixed dose

Metronidazole vs. Macrobid Indications

Metronidazole

Metronidazole is FDA-approved for a range of anaerobic and protozoal infections, including trichomoniasis, bacterial vaginosis, amebiasis, and intra-abdominal infections. Doctors also prescribe it off-label, often combined with other antibiotics, to treat Clostridioides difficile and Helicobacter pylori infections.

  • Trichomoniasis (symptomatic and asymptomatic)

  • Bacterial vaginosis

  • Amebiasis

  • Intra-abdominal infections (peritonitis, abscess)

Macrobid

Macrobid is FDA-approved only for acute, uncomplicated urinary tract infections caused by E. coli or S. saprophyticus. It is sometimes used off-label at a lower dose for long-term prevention of recurrent UTIs, but it is not approved for kidney infections or infections outside the bladder.

  • Acute uncomplicated UTI (cystitis)

  • Recurrent UTI prevention (off-label, low dose)

  • Not approved for pyelonephritis

  • Not approved for children under 12

Metronidazole vs. Macrobid Pros and Cons

Metronidazole

Metronidazole is inexpensive, covers a broad range of anaerobic bacteria and parasites, and comes in oral, IV, topical, and vaginal forms. It carries a boxed warning for carcinogenicity in animal studies and causes a severe reaction if combined with alcohol.

Pros

  • Broader spectrum: covers anaerobic bacteria and parasites

  • Available in oral, IV, topical, and vaginal forms

  • Roughly $15 to $40 per month, before insurance

Cons

  • Boxed warning for carcinogenicity in animal studies

  • Causes disulfiram-like reaction with alcohol

  • Metallic taste is a common complaint

  • Risk of seizures and peripheral neuropathy

Macrobid

Macrobid works almost entirely in the urinary tract, which limits its usefulness for infections elsewhere but keeps its side effect profile mostly local. It is contraindicated in significant kidney impairment and carries warnings for rare but serious lung and liver reactions with long-term use.

Pros

  • Minimal systemic absorption limits body-wide side effects

  • Still reliably effective against E. coli

  • First-line option for uncomplicated cystitis

Cons

  • Contraindicated with creatinine clearance under 60 mL/min

  • Risk of pulmonary fibrosis with long-term use

  • Roughly $80 to $200 per month, before insurance

  • Not effective for pyelonephritis or systemic infections

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.